• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Cardiovascular Devices

Endologix Inc

+ Add to Watchlist


14.5000 USD 0.1100 0.75%

As of 20:10:00 ET on 07/23/2014.

Snapshot for Endologix Inc (ELGX)

Open: 14.6800 Day's Range: 14.4800 - 14.7744 Volume: 180,245
Previous Close: 14.6100 52wk Range: 11.4700 - 18.8500 1-Yr Rtn: -6.69%

Stock Chart for ELGX

No chart data available.
  • ELGX:US 14.5100
  • 1D
  • 1M
  • 1Y
Interactive ELGX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ELGX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1755
Est. EPS (USD) (12/2014) -0.2880
Est. PEG Ratio -
Market Cap (M USD) 928.20
Shares Outstanding (M) 64.01
30 Day Average Volume 340,940
Price/Book (mrq) 8.3531
Price/Sale (ttm) 6.7207
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ELGX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ELGX

Endologix, Inc. develops, manufactures, sells, and markets minimally invasive treatments for vascular diseases. The Company's products include the Powerlink System, a catheter-based endoluminal stent graft that treats abdominal aortic aneurysms. Endologix's products are sold in the United States as well as international markets.

John McDermottChairman/CEORobert D MitchellPresident
Shelley B ThunenCFO/SecretaryCharles LoveVP:Clinical Affairs
More Company Profile & Key Executives for ELGX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil